Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-06-18 Sale | 2024-06-20 4:26 pm | Tarsus Pharmaceuticals Inc. | TARS | Farrow Jeffrey S See Remarks | 10,445 | $27.47 | $286,924 | 101,780 (Direct) | View |
| 2022-09-01 Sale | 2022-09-06 7:00 pm | Global Blood Therapeutics Inc. | GBT | Farrow Jeffrey S Chief Financial Officer | 31,441 | $68 | $2,137,988 | 32,360 (Direct) | View |
| 2020-07-13 Sale | 2020-07-15 5:11 pm | Global Blood Therapeutics Inc. | GBT | Farrow Jeffrey S Chief Financial Officer | 15,208 | $75 | $1,140,600 | 3,048 (Direct) | View |
| 2020-06-09 Sale | 2020-06-11 4:06 pm | Global Blood Therapeutics Inc. | GBT | Farrow Jeffrey S Chief Financial Officer | 15,208 | $67 | $1,018,936 | 18,256 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-17 Exercise | 2024-06-20 4:26 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Farrow Jeffrey S See Remarks | 27,881 | $0 | 101,780 (Direct) | View |
| 2024-03-07 Option Award | 2024-03-11 5:11 pm | N/A 2034-03-06 | Tarsus Pharmaceuticals Inc. | TARS | Farrow Jeffrey S See Remarks | 79,579 | $0 | 79,579 (Direct) | View |
Ownership(A) | 2023-04-28 8:01 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Farrow Jeffrey S See Remarks | 0 | $0 | 700 (Direct) | View |
| 2023-04-24 Option Award | 2023-04-26 5:05 pm | N/A 2033-04-23 | Tarsus Pharmaceuticals Inc. | TARS | Farrow Jeffrey S See Remarks | 274,922 | $0 | 274,922 (Direct) | View |
| 2022-10-05 Disposition | 2022-10-06 4:15 pm | N/A N/A | Global Blood Therapeutics Inc. | GBT | Farrow Jeffrey S Chief Financial Officer | 448,218 | $0 | 0 (Direct) | View |
| 2022-09-27 Exercise | 2022-09-29 8:48 pm | N/A N/A | Global Blood Therapeutics Inc. | GBT | Farrow Jeffrey S Chief Financial Officer | 23,653 | $16.4 | 37,038 (Direct) | View |
| 2022-09-27 Exercise | 2022-09-29 8:48 pm | N/A 2027-01-16 | Global Blood Therapeutics Inc. | GBT | Farrow Jeffrey S Chief Financial Officer | 23,653 | $0 | 37,038 (Direct) | View |
| 2022-09-01 Tax Withholding | 2022-09-06 7:00 pm | N/A N/A | Global Blood Therapeutics Inc. | GBT | Farrow Jeffrey S Chief Financial Officer | 1,885 | $68.15 | 32,360 (Direct) | View |
| 2022-09-01 Exercise | 2022-09-06 7:00 pm | N/A N/A | Global Blood Therapeutics Inc. | GBT | Farrow Jeffrey S Chief Financial Officer | 4,971 | $0 | 32,360 (Direct) | View |
| 2022-08-01 Tax Withholding | 2022-08-03 6:00 pm | N/A N/A | Global Blood Therapeutics Inc. | GBT | Farrow Jeffrey S Chief Financial Officer | 2,126 | $32.4 | 43,626 (Direct) | View |
| 2022-08-01 Exercise | 2022-08-03 6:00 pm | N/A N/A | Global Blood Therapeutics Inc. | GBT | Farrow Jeffrey S Chief Financial Officer | 12,290 | $0 | 43,626 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-03 8:52 pm | N/A N/A | Global Blood Therapeutics Inc. | GBT | Farrow Jeffrey S Chief Financial Officer | 63,964 | $0 | 107,963 (Direct) | View |
| 2022-03-01 Tax Withholding | 2022-03-03 8:52 pm | N/A N/A | Global Blood Therapeutics Inc. | GBT | Farrow Jeffrey S Chief Financial Officer | 1,315 | $29.87 | 107,963 (Direct) | View |
| 2022-03-01 Exercise | 2022-03-03 8:52 pm | N/A N/A | Global Blood Therapeutics Inc. | GBT | Farrow Jeffrey S Chief Financial Officer | 2,763 | $0 | 107,963 (Direct) | View |
| 2022-02-01 Tax Withholding | 2022-02-03 5:49 pm | N/A N/A | Global Blood Therapeutics Inc. | GBT | Farrow Jeffrey S Chief Financial Officer | 4,506 | $29.33 | 44,304 (Direct) | View |
| 2022-02-01 Exercise | 2022-02-03 5:49 pm | N/A N/A | Global Blood Therapeutics Inc. | GBT | Farrow Jeffrey S Chief Financial Officer | 18,040 | $0 | 44,304 (Direct) | View |
| 2021-08-01 Tax Withholding(A) | 2021-09-24 7:00 pm | N/A N/A | Global Blood Therapeutics Inc. | GBT | Farrow Jeffrey S Chief Financial Officer | 4,354 | $27.33 | 47,418 (Direct) | View |
| 2021-08-01 Exercise(A) | 2021-09-24 7:00 pm | N/A N/A | Global Blood Therapeutics Inc. | GBT | Farrow Jeffrey S Chief Financial Officer | 18,040 | $0 | 47,418 (Direct) | View |
| 2021-09-01 Tax Withholding | 2021-09-03 8:00 pm | N/A N/A | Global Blood Therapeutics Inc. | GBT | Farrow Jeffrey S Chief Financial Officer | 1,370 | $29.85 | 40,800 (Direct) | View |
| 2021-09-01 Exercise | 2021-09-03 8:00 pm | N/A N/A | Global Blood Therapeutics Inc. | GBT | Farrow Jeffrey S Chief Financial Officer | 2,762 | $0 | 40,800 (Direct) | View |
| 2021-08-01 Tax Withholding | 2021-08-03 6:19 pm | N/A N/A | Global Blood Therapeutics Inc. | GBT | Farrow Jeffrey S Chief Financial Officer | 4,354 | $27.33 | 47,418 (Direct) | View |
| 2021-08-01 Exercise | 2021-08-03 6:19 pm | N/A N/A | Global Blood Therapeutics Inc. | GBT | Farrow Jeffrey S Chief Financial Officer | 18,040 | $0 | 47,418 (Direct) | View |
| 2021-03-01 Option Award | 2021-03-03 7:32 pm | N/A 2031-02-28 | Global Blood Therapeutics Inc. | GBT | Farrow Jeffrey S Chief Financial Officer | 60,841 | $0 | 60,841 (Direct) | View |
| 2021-02-01 Tax Withholding | 2021-02-03 7:14 pm | N/A N/A | Global Blood Therapeutics Inc. | GBT | Farrow Jeffrey S Chief Financial Officer | 5,865 | $49.49 | 51,772 (Direct) | View |
| 2021-02-01 Exercise | 2021-02-03 7:14 pm | N/A N/A | Global Blood Therapeutics Inc. | GBT | Farrow Jeffrey S Chief Financial Officer | 24,166 | $0 | 51,772 (Direct) | View |
| 2020-08-01 Tax Withholding | 2020-08-04 9:26 pm | N/A N/A | Global Blood Therapeutics Inc. | GBT | Farrow Jeffrey S Chief Financial Officer | 5,946 | $67.48 | 57,637 (Direct) | View |
| 2020-08-01 Exercise | 2020-08-04 9:26 pm | N/A N/A | Global Blood Therapeutics Inc. | GBT | Farrow Jeffrey S Chief Financial Officer | 24,164 | $0 | 57,637 (Direct) | View |
| 2020-06-01 Option Award | 2020-06-03 7:52 pm | N/A N/A | Global Blood Therapeutics Inc. | GBT | Farrow Jeffrey S Chief Financial Officer | 42,400 | $0 | 42,400 (Direct) | View |
| 2020-02-01 Tax Withholding | 2020-02-04 8:18 pm | N/A N/A | Global Blood Therapeutics Inc. | GBT | Farrow Jeffrey S Chief Financial Officer | 4,398 | $65.26 | 132,499 (Direct) | View |
| 2020-02-03 Option Award | 2020-02-04 8:18 pm | N/A N/A | Global Blood Therapeutics Inc. | GBT | Farrow Jeffrey S Chief Financial Officer | 62,660 | $0 | 132,499 (Direct) | View |
| 2020-02-01 Exercise | 2020-02-04 8:18 pm | N/A N/A | Global Blood Therapeutics Inc. | GBT | Farrow Jeffrey S Chief Financial Officer | 18,126 | $0 | 132,499 (Direct) | View |
| 2019-12-13 Tax Withholding | 2019-12-17 8:21 pm | N/A N/A | Global Blood Therapeutics Inc. | GBT | Farrow Jeffrey S Chief Financial Officer | 2,479 | $76.88 | 28,799 (Direct) | View |
| 2019-12-13 Exercise | 2019-12-17 8:21 pm | N/A N/A | Global Blood Therapeutics Inc. | GBT | Farrow Jeffrey S Chief Financial Officer | 5,000 | $0 | 28,799 (Direct) | View |